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Organ remodelinge present as single cells or in small clusters distributed throughout the pancreas
of the Xenopus laevis tadpole. During metamorphic climax when the exocrine pancreas dedifferentiates to
progenitor cells, the β-cells undergo two changes. Insulin mRNA is down regulated at the beginning of
metamorphic climax (NF62) and reexpressed again near the end of climax. Secondly, the β-cells aggregate to
form islets. During climax the increase in insulin cluster size is not caused by cell proliferation or by acinar-
to-β-cell transdifferentiation, but rather is due to the aggregation of pre-existing β-cells. The total number of
β-cells does not change during the 8 days of climax. Thyroid hormone (TH) induction of premetamorphic
tadpoles causes an increase in islet size while prolonged treatment of tadpoles with the goitrogen
methimazole inhibits this increase. Expression of a dominant negative form of the thyroid hormone receptor
(TRDN) driven by the elastase promoter not only protects the exocrine pancreas of a transgenic tadpole from
TH-induced dedifferentiation but also prevents aggregation of β-cells at climax. These transgenic tadpoles do
however undergo normal loss and resynthesis of insulin mRNA at the same stage as controls. In contrast
transgenic tadpoles with the same TRDN transgene driven by an insulin promoter do not undergo down
regulation of insulin mRNA, but do aggregate β-cells to form islets like controls. These results demonstrate
that TH controls the remodeling of β-cells through cell–cell interaction with dedifferentiating acinar cells and
a cell autonomous program that temporarily shuts off the insulin gene.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe Xenopus laevis pancreas contains both exocrine and endocrine
components like other vertebrate pancreases including cells that
synthesize insulin (β-cells), glucagon (α-cells), somatostatin (δ-cells)
and pancreatic polypeptide (PP cells) (Kelly and Melton, 2000; Maake
et al., 1998). In X. laevis the number of these endocrine cells increases
in proportion to the increasing size of the pancreas as the tadpole
grows throughout premetamorphosis up to the climax of metamor-
phosis (Maake et al., 1998). Most of these hormone-producing cells
exist as single cells or small aggregates in premetamorphic tadpoles
(Kelly and Melton, 2000). Unlike mammals, the islets in mature
X. laevis frogs consist exclusively of β-cells with an occasional
association with α-cells (Horb and Slack, 2002). During climax, the
ﬁnal stage of metamorphosis that lasts about 8 days, many major
developmental changes occur including remodeling of the pancreas
(Dodd and Dodd,1976). The pancreas shrinks about 80% in size (Bollin
et al., 1973), and loses about 40% of its cells (Mukhi et al., 2008). The
tadpole acinar cells dedifferentiate to a progenitor state and begin to
redifferentiate at the end of metamorphosis (Mukhi et al., 2008). The
shrinkage of the pancreas brings the various endocrine cells closerl rights reserved.together (Maake et al., 1998). In addition a “maturation” of the
pancreatic endocrine systemhas beenproposed at climax (Accordi and
Chimenti, 2001; Maake et al., 1998), which involves limited cell death
and changes in insulin expression.
In this paper we show that the dispersed β-cells in the tadpole
pancreas aggregate to form islets during metamorphic climax. This
aggregation of pre-existing β-cells depends upon the TH-induced
dedifferentiation of the exocrine pancreas. In contrast, a β-cell
autonomous TH-controlled program induces a cessation of insulin
mRNA expression brieﬂy during climax followed by reexpression of
the gene at the end of climax. Following metamorphosis the islets
increase in size as the entire pancreas grows in the frog.
Materials and methods
Plasmid construct, transgenesis and animal care
Transgenic X. laevis were prepared with plasmids with the rat
elastase promoter (Kruse et al., 1993) driving GFP (pElastase-GFP) and
a dominant negative form of thyroid hormone receptor alpha fused by
a small linker with GFP (pElastase-TRDN-GFP) (Mukhi et al., 2008).
We tested mouse (Hara et al., 2003) and zebraﬁsh (Pisharath et al.,
2007) insulin promoters in transgenic X. laevis. Neither of these
constructs expressed in X. laevis β-cells. A 5407 base pair DNA region
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sequence information obtained from the JGI genome sequence
assembly (scaffold 419, bps 877137–872185). The sequence has been
deposited into Genbank (accession number EU853828). This 5.4 kb
promoter DNA drives expression only in β-cells (see Fig. 3). The
majority but not all of insulin antibody reacting cells expressed the
reporter throughout tadpole development, metamorphosis and in
froglets. Transgenic animals were prepared with this insulin promoter
controlling either GFP or the TRDN-GFP. The pInsulin-TRDN-GFP
construct was made by amplifying the 5.4 kb fragment of the
promoter by PCR using primers that incorporated a Xho1 site at the
5′ end and Sma1 at the 3′ end, and this PCR-product was ligated into
the pCS2-CMV-TRDN-ﬂex-GFP that had been cleaved by Sal1 (at 5′)
and HindIII (at 3′) replacing the existing CMV promoter sequence. The
pElastase-TRDN-GFP and pInsulin-TRDN-GFP animals used were F0
generation. Breeding a transgenic male with a wild type female
generated the F1 pElastase-GFP animals. Tadpoles were raised in a
ﬂow-through system with controlled photoperiod at room tempera-
ture. Tadpoles and frogs were anesthetized with MS-222 (3-
aminobenzoic acid ethyl ester, Sigma) and their pancreases were
isolated for sections. Tadpole development was staged according to
Nieuwkoop and Faber (1956).
Other plasmids used for in situ hybridization were X. laevis
neurogenin 3 (EU917071), X. laevis nkx6.1 (NM_001099916), and X.
laevis Insm1 (EU076904).
3,5,3′-Triiodothyronine (T3) and methimazole treatment of
premetamorphic tadpoles
Premetamorphic (NF55) tadpoles were treated with 10 nM T3
added to their rearing medium (0.1× MMR; 10 mM NaCl, 0.2 mM KCl,
0.1 mM MgCl2, 0.2 mM CaCl2, 0.5 mM Hepes, pH 7.5) for as long as
6 days. The water and T3 were changed every other day. Animals were
collected for assay of β-cell clustering at days 3 and 6.
Metamorphosis in X. laevis can be inhibited by disrupting the
production of thyroid hormone (TH) by the thyroid gland with
methimazole (Cooper et al., 1984). Premetamorphic wild-type
tadpoles (NF55) were reared (at ≤5 animal/L; n=5/6 per group)
with or without 1 mM methimazole (Sigma) in 0.1× MMR until the
control group completed metamorphosis from tadpoles to froglets
(NF66), in about a 4-week period. The rearing water with added
methimazole was changed once a week.
Bromodeoxyuridine (BrdU) labeling, immunohistochemistry, in situ
hybridization and β-cell counts
Premetamorphic (NF55), beginning climax tadpoles (NF58/59),
and 1-week old froglets were injected intraperitoneally every other
day for 10 days with 10 μl of 100 mM BrdU. The animals were fed
throughout the experiment. The climax tadpoles completed meta-
morphosis and developed into froglets during that period. The
premetamorphic tadpoles developed to NF56/57. Animals were
euthanized 24 h after the last BrdU injection, pancreases were ﬁxed
and processed for immunohistochemical analysis.
Samples for immunohistochemistry and in situ hybridizationwere
ﬁxed in 4% paraformaldehyde, embedded in OCT compound, and
cryosectioned as described earlier (Cai and Brown, 2004). The DIG-
labeled antisense RNA probes were prepared for insulin, ngn3,
xnkx6.1, and Insm1 as described earlier (Berry et al., 1998). BrdU-
immunostaining was performed as described (Schreiber et al., 2005).
The primary antibodies used for immunohistochemistry were guinea
pig anti-insulin (Linco Research) at 1:500 dilution; mouse anti-BrdU
(Becton Dickinson Immunocytochemistry Systems) at 1:30 dilution;
rabbit anti-GFP (Torrey Pines Biolabs, Inc) at 1:500 dilution, and
mouse anti-PCNA (Sigma) at 1:1500 dilution. The antigen retrieval
procedure (Vector laboratory) was followed for the PCNA reaction.Images were takenwith a Nikon Eclipse E800microscope and SPOT RT
digital camera (Diagnostic Instruments, USA). In each group, 5–10
wild type or transgenic animals were used for in situ hybridization,
immunostaining and histology. The number of insulin positive β-cells
was counted from wild type tadpoles and frogs as well as transgenic
animals, T3-induced premetamorphic wild-type tadpoles and methi-
mazole treated tadpoles (n≥5/group). Transverse sections were
made through the entire pancreas and, 15 to 20 sections spanning the
entire depth of each pancreas at equal intervals were counted for the
number of insulin positive cells. For each animal, the average β-cell
cluster size (islet size) was estimated by dividing the total number of
β-cells by the total number of clusters counted for that animal. The
total number of β-cells was estimated for the entire pancreas at the
beginning of climax (NF58/59), the middle of climax (NF62) and the
end of climax (NF66) by extrapolating the numbers from representa-
tive sections. These two stages span the range in islet size that occurs
during climax. Neurogenin-3 (ngn3) positive cells were counted in
representative sections and the number estimated per unit area of
pancreas. The area of each section was estimated by digital imaging
using software (Image J, NIH, USA). An analysis of variance followed
by Duncan's multiple range test (pb0.05) was performed on the
cluster size using statistical software (SuperANOVA, Abacus Concepts,
Berkeley, CA) and expressed as ±SEM. The β-cell cluster sizes of the
animals at different stages are represented by pie-diagrams.
Results
β-cell clustering during spontaneous and induced metamorphosis
Throughout premetamorphic stages (NF55) insulin-producing
cells are scattered throughout the pancreas in small clusters (Fig. 1).
The average islet size at NF55 is about 2 cells, and more than 95% of
islets consist of ≤5 cells per cluster (Fig. 1C). By the end of
prometamorphosis (NF58) about 62% of β-cells are still in small
clusters. The climax of metamorphosis (NF59–NF66) takes about
8 days. During climax there is a signiﬁcant increase in average cluster
size (Fig. 1). To compare the cluster sizes at climax in spontaneous
metamorphosis with that of T3-induced metamorphosis, premeta-
morphic tadpoles were exposed to 10 nM T3 for 6 days and their
pancreases were collected at day-3 and 6 to analyze the β-cell cluster
size. There was a signiﬁcant increase in clustering of β-cells after
6 days of TH treatment (Fig. 1D) compared to the unexposed
premetamorphic tadpoles. To further strengthen the importance of
TH to β-cell clustering we inhibited metamorphosis pharmacologi-
cally by growing tadpoles in the goitrogen methimazole. Premeta-
morphic tadpoles (NF55) were treated with methimazole for the
same duration of time that it took control siblings to advance to
froglets (approximately 4 weeks). Although methimazole-treated
animals continued to grow in size over this period of time, the insulin
cells remained as small clusters (Fig. 1C). In additionwe observed that
giant tadpoles (Rot-Nikcevic and Wassersug, 2004) which do not
metamorphose after more than one year retain the size distribution of
β-cell aggregates of a premetamorphic tadpole (data not shown).
These experiments demonstrate the requirement of TH for islet
formation.
The increase in cluster size is not due to cell replication or
transdifferentiation of exocrine cells
The TH-induced increase in cluster size at climax could be due to
replication of β-cells, the transdifferentiation of exocrine cells to β-
cells, or the aggregation of pre-existing β-cells. To investigate the role
of cell proliferation in the increase in islet size, we injected BrdU every
other day during climax fromNF59 to NF66 (10 days). On the 11th day
all of the tadpoles had completed metamorphosis (NF66). The same
scheme of BrdU labeling was carried out with premetamorphic
Fig. 1. Clustering of β-cells during spontaneous and T3-induced metamorphosis of X. laevis. (A) premetamorphic tadpoles (NF54); (B) froglet (NF66). A and B panels are stained with
an insulin antibody (red) and DAPI (blue). (C) Average number of insulin cells per islet increases as the animal proceeds to metamorphosis. The pie-diagram above each bar
represents the distribution of the different sized clusters marked with different colors as described in the insert. For example the blue color represents the fraction of total islets that
consist of 1–5 β-cells. (a) The average cluster sizes at prometamorphosis and in the methimazole arrested animals is signiﬁcantly higher (pb0.05) than that of premetamorphic
stages. Rearing tadpoles inmethimazole (MMI) inhibits TH-induced changes including enlargement of islets. (b) The cluster size in froglets is larger than any of the tadpole islet sizes.
(D) Exogenous triiodothyronine (T3) induces an increase in β-cell cluster size in premetamorphic tadpoles. Premetamorphic tadpoles were exposed to 10 nM T3 in rearing water and
the insulin cluster sizes were calculated at 3 and 6-day of exposure and compared with the cluster size of control animals. There was a signiﬁcant increase in cluster size on the 6th
day of T3 treatment (pb0.05). Scale bar (A and B) 20 μm.
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sets of animals were doubly immunostained with antibodies against
BrdU and insulin (Fig. 2A). Many β-cells in the premetamorphic
tadpole (Fig. 2Aa) and the growing frog pancreases (Fig. 2Ac) were
doubly labeled. However no insulin-producing cell incorporated BrdU
during climax (Fig. 2Ab). Reaction of the same stage pancreases with
PCNA antibody conﬁrms the absence of β-cell replication during
climax (Fig. 2Ae). In the weeks after metamorphosis there is an active
resumption of DNA synthesis in the insulin-producing β-cells of the
growing islets (Fig. 2Ac, f). We conclude that DNA replication does not
play a role in islet formation at climax, but it is very active and
undoubtedly responsible for the increase in the number of tadpole β-
cells (Fig. 2Aa) and the growth of the islets in the frog after
metamorphosis (Fig. 2Ac, f).
In our previous work we demonstrated that the X. laevis exocrine
pancreas undergoes dedifferentiation during metamorphic climax
followed by redifferentiation in the frog (Mukhi et al., 2008). Since
pancreatic acinar cells demonstrate plasticity and have been proven to
give rise to insulin producing cells (Bouwens, 1998), one hypothesis to
explain the increase in islet size during climax is that the dediffer-
entiated exocrine cells redifferentiate into β-cells. In pElastase-GFP
transgenic tadpoles the GFP mRNA expressed in acinar cells is down
regulated at climax (Fig. 2Bb), but the protein is stable throughout
climax (Fig. 2d–f) when the islets are enlarging. If transdifferentiation
of exocrine cells contributes to islet enlargement then some islet cells
should be GFP positive. An extensive immunohistochemical search
never revealed any insulin-reacting cells that were also positive forGFP (Fig. 2Be, f). We conclude that dedifferentiated acinar cells do not
contribute to formation of islets at the climax of metamorphosis.
Increase in cluster size is due to aggregation of pre-existing β-cells and
requires exocrine remodeling
During climax about 40% of cells in the pancreas are lost
(Mukhi et al. 2008). However, the number of insulin positive cells does
not change at climax when the pancreas has reached its lowest cell
number. We counted the total number of β-cells that stain with an
insulin antibody at pro-metamorphosis (NF58/59) (5050+/−943),
the middle of climax (NF62) (6383+/−320) and at the end of climax
(NF66) (4296+/−660). There is no statistical difference between
these three numbers (ANOVA, pN0.05).
From the previous spontaneous and T3 induced experiments it was
evident that TH plays an important role in the aggregation of β-cells at
climax. To further investigate if this aggregation is a cell autonomous
or cell–cell interaction program, we utilized transgenic animals with a
dominant negative form of the thyroid hormone receptor (TRDN)
driven by either the X. tropicalis insulin promoter or the rat elastase
promoter. The insulin promoter controls expression exclusively in β-
cells and not in exocrine cells (Figs. 3A–C) while the elastase promoter
expresses exclusively in the acinar cells of the exocrine pancreas
(Mukhi et al., 2008). The β-cells aggregated normally during climax in
the pInsulin-TRDN transgenic animals. However, expression of TRDN
in the exocrine pancreas controlled by the elastase promoter inhibited
this clustering (Fig. 3G). We conclude that the dedifferentiating
Fig. 2. Aggregation of pre existing β-cells give rise to bigger islets at the end of climax. (Aa–c) β-cell proliferation at different stages of metamorphosis. BrdU was injected
intraperitoneally into staged animals every other day for 10 days and pancreases were collected on the 11th day from (a) NF55 tadpoles; (b) climax (NF59–NF66) and (c) growing
froglets. BrdU (green) and insulin (red) were detected by antibodies. Cell cycle activity monitored by immunostaining with a PCNA antibody (green) and insulin (red). (d) NF55
tadpoles; (e) climax (NF59–NF66) and (f) growing froglets. (B) pElastase-GFP transgenic animal. (a–c) in situ hybridization of GFP mRNA; (d–f) immunohistochemistry for GFP
(green) and insulin (red). (a, d) NF55; (b, e) NF62; (c, f) NF66. Scale bar 40 μm.
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β-cells during climax.
Twomonths after metamorphosis, the small islets in the pElastase-
TRDN transgenic frogs increased to the same size as the control frogs.
We have raised several pElastase-TRDN frogs to sexual maturity and
the pInsulin-TRDN for several months as frogs. Neither group has
shown any morbidity. In addition the pElastase-TRDN frogs have
normal glucose tolerances (unpublished data). The Insulin-TRDN frogs
have not been tested for glucose tolerance.
Insulin-producing cells have a cell autonomous response to TH at
metamorphic climax
A brief drop in insulin protein at climax has been reported (Milano
and Chimenti, 1995) suggesting that insulin gene expression might be
altered at climax. We analyzed insulin mRNA by in situ hybridization
throughout metamorphosis (Fig. 4). Tadpole and adult β-cells stained
strongly with an insulin mRNA probe (Figs. 4A and D), whereas, at
early climax (Fig. 4B) the islet cells stained weakly with this probe.
The intensity of staining increases at the end of climax (Fig. 4C) when
tail resorption is complete. The insulin protein persists throughout
metamorphosis (Fig. 2B). The down-regulation of insulin mRNA atclimax was inhibited in pInsulin-TRDN-GFP animals (Figs. 4E and F),
but these animals aggregated their β-cells normally (Figs. 3 and 4F). In
contrast to pInsulin-TRDN-GFP, the insulin mRNA level in pElastase-
TRDN-GFP animals was comparable at each stage to that of wild-type
siblings. The down regulation of insulin mRNA in wild-type (Fig. 4B)
and pElastase-TRDN-GFP (Fig. 4G) but not in pInsulin-TRDN-GFP
animals (Figs. 4E, F) substantiates the existence of a TH-dependant
cell-autonomous program in insulin producing cells.
To determine whether this down regulation of insulin mRNA is
accompanied by a return to a progenitor state analogous to the
dedifferentiation of the exocrine cells we screened for the expression
of several known genes by in situ hybridization. We examined the
expression of both pan-endocrine and β cell speciﬁc markers,
including ngn3, xnkx6.1, and Insm1. No cells expressed the latter
two genes at any stage of metamorphosis or in the pancreas of young
froglets. The numbers of ngn3 positive cells were counted and
represented quantitatively. Premetamorphic and adult frogs had very
few ngn3 positive cells. At the beginning of metamorphic climax
(NF62) ngn3 positive cells started appearing, and they peaked in
abundance at NF66 (Fig. 5). One week postmetamorphosis the ngn3
cells were reduced drastically (Fig. 5B). These ngn3 positive cells are
distributed throughout the pancreas. Sometimes they are associated
Fig. 3. Aggregation of β-cells is dependant on exocrine remodeling. Simultaneous immunohistochemistry of insulin (red) and GFP (green) of transgenic frogs at NF66. (A–C) pInsulin-
TRDN-GFP; (D–F) pElastase-TRDN-GFP. The third panel of each (C, F) merge the ﬁrst two panels. (G) Quantitative measurement of islet size and pie-distribution of islet cluster at
NF66 of wild type (represented from Fig. 1 for comparison) and the two transgenic frogs. Scale bar 40 μm.
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localize with insulin positive cells (Fig. 5A). The ngn3 positive cells
might be involved in new islet formation or contribute ultimately to
the existing islets. Ngn3 positive cells were abundant in pInsulin-
TRDN-GFP but almost totally absent in pElastase-TRDN-GFP animals
(Fig. 5) suggesting their origin from exocrine precursors.
At NF62 when insulin mRNA is at its lowest none of the insulin
protein-containing cells were positive for ngn3, xnkx6.1 or Insm1.
Whatever the explanation may be for brieﬂy shutting off insulin
mRNA synthesis there is no evidence that the β-cells return to a
progenitor state.
Discussion
The insulin secreting β-cells in X. laevis have been studied during
embryogenesis and metamorphosis (Horb and Slack, 2002; Kelly and
Melton, 2000; Maake et al., 1998). Farrar and Hulsebus (1988)
reported a loss of β-cell volume that matched the change in volume of
the exocrine pancreas at metamorphosis. Maake et al. (1998)
described “disintegration” of a small number of β-cells at the onset
of metamorphosis followed by an increase in β-cell number starting atNF63 and continuing until NF66. Milano and Chimenti (1995)
interpreted a change in intensity of an immunoreaction with an
insulin antibody as evidence of islet cell degeneration at the climax of
metamorphosis. Kuang (1983) concluded that some β-cell degenera-
tion occurs at climax of Rana pipiens after pancreas shrinkage. In
agreement with Leone et al. (1976) we found no evidence of islet
degeneration, apoptosis, or a reduction in the total number of β-cells
during the dramatic exocrine remodeling that occurs at metamorphic
climax. However, there is a striking down regulation of insulin mRNA
in early climax that is controlled by TH (Fig. 4) and so brief that
substantial insulin protein remains at all times in the β-cells.
Expression of the TRDN transgene under control of the insulin
promoter (Fig. 4) inhibits this loss of insulin mRNA.
During pre and prometamorphosis (NF50–57) single cells and
small aggregates of β-cells synthesize insulin (Maake et al., 1998). Frye
(1964) described an increase in islet size as “maturation of the insulin
producing machinery”. When the exocrine pancreas shrinks at climax
(NF 59–66), the density of all of the endocrine cells increases about 10
fold (Maake et al., 1998). The hormone-producing cells other than the
β-cells remain as single cells or small clusters, but the insulin-
producing β-cells form islets during the eight days of climax (Fig. 1).
Fig. 4. Insulin mRNA in situ hybridization of control and transgenic pancreases at varying stages. These reactions were carried out together and developed for the same time. (A)
Control premetamorphic pancreas has small islets that stain for insulin mRNAwith similar intensity as (D) adult islet cells. (B) At NF62 most of the insulin mRNA is down regulated
and reexpression begins at (C) the end of climax NF66. The pInsulin-TRDN transgenic pancreas does not down regulate insulin mRNA at (E) NF62 or (F) NF66, but its ability to
aggregate by NF66 is not impaired. (G) pElastase-TRDN-GFP at NF66 showed similar insulin mRNA down regulation as that of wild-type but the β-cells do not aggregate. Scale bar
equals 40 μm.
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(Frye, 1964) accounts for the absence of an obvious phenotype in the
transgenics described here.
Mammalian islets are generated in a multistep process involving
differentation of progenitor cells, migration of these cell, and
aggregation of these cells into islets (Kim and Hebrok, 2001).
Migration of islet forming cells has been demonstrated to be
controlled by matrix metalloproteinases (MMPs) in rat pancreatic
development (Miralles et al., 1998). Although we have not explored a
possible role of MMPs in pancreas remodeling several of these
proteases are induced by TH (Brown et al., 1996) and have been
implicated in other metamorphic programs (Jung et al., 2004;
Patterton et al., 1995). TH controls exocrine pancreas remodeling in
X. laevis, which in turn regulates the formation of islets during climax
(Fig. 3). The transgenic tadpoles that cannot dedifferentiate theirexocrine pancreas do not aggregate their β-cells during climax.
However, these same transgenic animalsmonths aftermetamorphosis
form large islets even though the exocrine pancreas is still very
abnormal (Mukhi et al., 2008). We have observed extensive β-cell
replication during the early stages of growth of the frog pancreas
(Fig. 2) after the climax of metamorphosis. We conclude that the
increase in β-cells that takes place during tadpole growth and the
enlargement of the islets in maturing frogs including the transgenic
TRDN animals is due mainly to cell proliferation that is not under the
control of TH.We found no evidence that β-cells dedifferentiate like the
exocrine pancreas since transcription factors known to be crucial for
insulin speciﬁcation (ngn3, xnkx6.1, Insm1) are not activated in these
islet cells at NF62, the stage when insulin mRNA is at its lowest level.
Ngn3 is a basic helix–loop–helix transcription factor that marks
the progenitors of endocrine cells and is considered as a master
Fig. 5. Screening of progenitor cell markers revealed the existence of (A) ngn-3 positive cells at metamorphic climax. (a) Ngn-3 in situ at NF66; (b) insulin immunohistochemistry on
the same section and (c) merger of a and b. Ngn3 cells never co localize with insulin staining cells. (B) Quantitative estimation of ngn3 positive cells at different developmental stages
of control and the two different strains of transgenic animals. Scale bar equals 40 μm.
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expression has not been detected in the adult rodent pancreas
(Gu et al., 2002). In a recent study Xu et al. (2008) demonstrated that
after partial duct ligation new β-cells are formed from an ngn3-
positive progenitor population. In our survey for cells expressing these
genes we found a brief period at the end of climax when individual
ngn3 positive cells were present (Fig. 5). The activation of ngn3 in
these cells depended upon exocrine remodeling implying that they
either originate from dedifferentiated tadpole acinar cells or respond
to an exocrine signal. The ngn3 positive cells appear at the end of
metamorphosis just before β-cell replication becomes active in the
froglet. We have not traced the fate of the ngn3 positive cells or
analyzed further the source of the newly replicated β-cells in the
growing frog. However we can now explore the possibility that new
islets in the frog may be derived from these ngn3 positive cells while
the old islets, formed at climax from tadpole β-cells, enlarge by
replication of preexisting β-cells. The incorporation of Brdu and the
appearance of PCNA in the nuclei of β-cells in the growing froglet
(Fig. 2) suggest that differentiated cells that are already producing
insulin replicate in the growing frog. The incorporation of BrdU but
the absence of PCNA in the nuclei of growing tadpoles (Fig. 2)
suggests that the tadpole β-cells were assayed in a different phase of
the cell cycle than the frog pancreas.
The value of adding X. laevis metamorphosis to the other highly
studied systems used to study pancreas development is that
remodeling is a normal part of the life cycle of the frog and is initiated
synchronously in the entire pancreas by a single hormone.
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